Clinical Phytoscience (May 2020)

Carbohydrate digestive enzymes are inhibited by Poincianella pluviosa stem bark extract: relevance on type 2 diabetes treatment

  • Camila Gabriel Kato-Schwartz,
  • Anacharis Babeto de Sá-Nakanishi,
  • Ana Carolina Guidi,
  • Geferson de Almeida Gonçalves,
  • Fernanda Giacomini Bueno,
  • Beatriz Petroncine Martins Zani,
  • João Carlos Palazzo de Mello,
  • Paulo Sérgio Alves Bueno,
  • Flavio Augusto Vicente Seixas,
  • Adelar Bracht,
  • Rosane Marina Peralta

DOI
https://doi.org/10.1186/s40816-020-00177-w
Journal volume & issue
Vol. 6, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Background The stem bark aqueous alcohol extract of Poincianella pluviosa (PPSB extract) is rich in bioactives including gallic acid, gallic acid methyl ester, pyrogallol, ellagic acid, corilagin, 1,4,6-tri-O-galloyl-glucose, 1,2,3,6-tetra-O-galloyl-glucose, 1,2,3,4,6-penta-O-galloyl-glucose, tellimagrandin I, tellimagrandin II, mallotinic acid, mallotusinic acid, and geraniin. The aim of the present study was to evaluate the antioxidant activity of the PPSB extract as well as its inhibitory action on carbohydrate digestive enzymes relevant to type 2 diabetes. Results The PPSB extract was prepared using a mixture of 40% ethanol and 60% distilled water. The PPSB extract showed high antioxidant activities and inhibited several carbohydrate digestive enzymes. The IC50 values for inhibiting in vitro salivary amylase, pancreatic amylase, intestinal β-galactosidase and intestinal invertase were, respectively, 250 ± 15, 750 ± 40, 25 ± 5, and 75 ± 8 μg/mL. In vivo inhibition of the intestinal starch absorption was confirmed by determination of blood glucose levels in rats before and after administration of starch by gavage with or without different amounts of PPSB extract. Docking simulations performed on three different programs to rank the extract compounds most likely to bind to porcine pancreatic α-amylase suggest that geraniin is likely to be the P. pluviosa extract compound that presents the greatest binding potential to the pancreatic alpha-amylase. However, the total inhibitory action of the PPSB extract is likely to result from a summation of effects of several molecules. Furthermore, the PPSB extract did not present acute toxicity nor did it present mutagenic effects. Conclusion It can be concluded that the PPSB extract is potentially useful in controlling the postprandial glycaemic levels in diabetes. Further clinical studies with the extract are needed, however, to confirm its potential use in the management of type 2 diabetes.

Keywords